Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study
Colquhoun D, Vaughn M, Bash L, Janda A, Shah N, Ghaferi A, Sjoding M, Mentz G, Kheterpal S, Committee M, Craft R, Domino K, Freundlich R, Mathis M, McCormick P, Naik B, Ruiz J, Schonberger R, Schroeder R, Stewart A, Taicher B, Tingle S, Togioka B, Urman R, Vachhani S. Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study. British Journal Of Anaesthesia 2022, 130: e148-e159. PMID: 35691703, PMCID: PMC9875908, DOI: 10.1016/j.bja.2022.04.023.Peer-Reviewed Original ResearchMeSH KeywordsCholinesterase InhibitorsCohort StudiesHumansNeostigmineNeuromuscular BlockadeNeuromuscular Blocking AgentsPostoperative ComplicationsRespiratory InsufficiencyRetrospective StudiesSugammadexConceptsPostoperative pulmonary complicationsPulmonary complicationsNon-emergency surgeryRespiratory failureCohort studyNeuromuscular blockReversal agentsAnesthesiologists physical status 3Primary composite outcomeCohort of patientsUse of sugammadexIntra-abdominal surgeryOccurrence of pneumoniaBody mass indexSource of morbidityNeuromuscular blocking agentsStatus 3Complication outcomesComposite outcomeMajor surgeryPrimary outcomeMass indexTracheal intubationGeneral anesthesiaMulticenter Perioperative Outcomes Group